Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Nice gains

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 03, 2021 11:28pm

234 Views

Post# 32213200

RE:RE:RE:RE:RE:RE:RE:RE:Nice gains

Does this mean Sigilon is over valued or is SVA undervalued? I'd say a bit of both so for that reason I'll short Sigilon.

I think a lot of the presentation has already been priced in. Next thing we need is a licensing deal that brings $ to the coffers. Let's see what happens in the coming days leading to the presentation and Donald Chump leaving the whitehouse. Shouldn't have a big effect on the market as i'm sure it's all factored in but ya'll know how these things trigger temporary ups and downs.

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features